Physician

Abu Hurairah, M.D.

According to 2025 Medicare claims, Abu Hurairah, M.D. (NPI: 1184904377) practices gastroenterology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Orange, FL. This provider's primary affiliated billing organization is FLORIDA HOSPITAL MEDICAL GROUP INC (NPI: 1225034234; TIN: 593214635) and primary practice location at 32703-9210.

Hurairah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 512 traditional Medicare patients, billed 1,129 HCPCS/CPT codes, and received $106,740 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 781 prescription claims across 322 beneficiaries totaling $364,786 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 11 records totaling $253. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $963 to $364,786. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$66K$131K2018 Medicare payment: $32,623 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $122,856 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $114,038 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $121,995 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $131,189 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $85,206 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $106,740 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018179368$32,623
20195121,450$122,856
20205111,367$114,038
20215401,347$121,995
20226481,491$131,189
2023447913$85,206
20245121,129$106,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$233K$466K2016 Drug cost: $963 (USD; Tot_Drug_Cst)2017 Drug cost: $4,903 (USD; Tot_Drug_Cst)2018 Drug cost: $4,860 (USD; Tot_Drug_Cst)2019 Drug cost: $122,362 (USD; Tot_Drug_Cst)2020 Drug cost: $465,546 (USD; Tot_Drug_Cst)2021 Drug cost: $408,371 (USD; Tot_Drug_Cst)2022 Drug cost: $371,479 (USD; Tot_Drug_Cst)2023 Drug cost: $297,678 (USD; Tot_Drug_Cst)2024 Drug cost: $364,786 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161630$963
20172872$4,903
20183984$4,860
201974139$122,362
2020217616$465,546
2021240729$408,371
2022276739$371,479
2023264678$297,678
2024322781$364,786

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6969$115
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes175181$100
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more110147$92
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope115115$72
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes143236$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LinzessLinaclotide361,500$26,208
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates151194$9,524
MesalamineMesalamine12360$6,621
UrsodiolUrsodiol16660$1,310
Pantoprazole SodiumPantoprazole Sodium1478,085$1,237

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$253ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abu Hurairah, M.D.?

Tedicare shows public-source Medicare data for Abu Hurairah, M.D. (NPI 1184904377), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abu Hurairah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abu Hurairah, M.D.?

Abu Hurairah, M.D. is linked to FLORIDA HOSPITAL MEDICAL GROUP INC (billing NPI 1225034234) in the available physician profile data.

Does Abu Hurairah, M.D. have Open Payments data?

Abu Hurairah, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.